Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat in Chronic Stable Angina
NCT01763996Phase 4Completed
- Sponsor
- Takeda
- Start
- May 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of febuxostat in angina pectoris (2 arms), sponsored by Takeda. Primary endpoint: Change in Coronary Artery Flow From Rest to Isometric Handgrip (IHG) Exercise at 12 weeks. Started May 2013; status: completed.
02
Drugs
febuxostat
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT01763996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01763996.